Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner

• Aidi Gao,
• Zhenzi Su,
• Zengfu Shang,
• Chao He,
• Dongliu Miao,
• Xiaoqing Li,
• Shitao Zou,
• Weiqun Ding,
• Yue Zhou,
• Ming Sun,
• Jundong Zhou

Affiliations

Aidi Gao

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University

Zhenzi Su

The Affiliated Suqian Hospital of Xuzhou Medical University and Nanjing Drum Tower Hospital Group Suqian Hospital

Zengfu Shang

School of Radiation Medicine and Protection, Medical College of Soochow University

Chao He

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University

Dongliu Miao

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University

Xiaoqing Li

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University

Shitao Zou

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University

Weiqun Ding

Department of Pathology, University of Oklahoma Health Science Center

Yue Zhou

Department of Thoracic Surgery, First Affiliated Hospital of Nanjing Medical University

Ming Sun

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School

Jundong Zhou

Suzhou Cancer Center Core Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University